XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

XIX International AIDS Conference. Sharon Lewin from Monash University in Melbourne discusses the possibilities of ending AIDS and scientific breakthroughs during the 30 years of the epidemic, for instance the discovery that some people are resistant to HIV.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Dr Daria Hazuda from MSD, who has been involved in antiretroviral drug development during the past 20 years, holds a presentation. She is also interviewed about leadership and the progress of ARV and vaccine development.

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.

This film tells the US story of the AIDS epidemic starting in the early 1980's. Scientists and activists, both pioneers and youths of today, talk about research, prevention, treatment and care. They also discuss stigma, homophobia and poverty as closely related to HIV and AIDS.

Anthony Fauci is interviewed about the progression from HIV to AIDS. He talks about HIV long-term survivors and different aspects of non-progression to AIDS. He also reflects on the future for antiretroviral drugs and HIV vaccines.